APA (7th ed.) Citation

HR, K., & R, K. (2023). A multitier virtual screening of antagonists targeting PD-1/PD-L1 interface for the management of triple-negative breast cancer. Medical oncology (Northwood, London, England), 40(11), 312. https://doi.org/10.1007/s12032-023-02183-7

Chicago Style (17th ed.) Citation

HR, Krishnamoorthy, and Karuppasamy R. "A Multitier Virtual Screening of Antagonists Targeting PD-1/PD-L1 Interface for the Management of Triple-negative breast cancer." Medical Oncology (Northwood, London, England) 40, no. 11 (2023): 312. https://doi.org/10.1007/s12032-023-02183-7.

MLA (9th ed.) Citation

HR, Krishnamoorthy, and Karuppasamy R. "A Multitier Virtual Screening of Antagonists Targeting PD-1/PD-L1 Interface for the Management of Triple-negative breast cancer." Medical Oncology (Northwood, London, England), vol. 40, no. 11, 2023, p. 312, https://doi.org/10.1007/s12032-023-02183-7.